Monogenic X-linked mental retardation: Is it as frequent as currently estimated? The paradox of the ARX (Aristaless X) mutations

European Journal of Human Genetics

Volumn 12, Issue 9, 2004, Pages 689-693

  Mandel, Jean Louis ^a,c   Chelly, Jamel ^b  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b INSTITUT COCHIN   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE DERIVATIVE; HOMEODOMAIN PROTEIN;

ARTICLE; CHROMOSOME XP; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENETIC COUNSELING; GENETIC TRAIT; HUMAN; INTELLIGENCE QUOTIENT; MALE; MONOGENIC DISORDER; PRIORITY JOURNAL; SEX DIFFERENCE; SEX RATIO; X CHROMOSOME; X LINKED MENTAL RETARDATION;

CHROMOSOMES, HUMAN, X; HOMEODOMAIN PROTEINS; HUMANS; MENTAL RETARDATION, X-LINKED; MUTATION; PREVALENCE; TRANSCRIPTION FACTORS;

EID: 4644244222     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201247     Document Type: Article

References (40)

1. Stevenson RE, Schwartz CE, Schroer RJ: X-Linked Mental Retardation. Oxford: Oxford University Press, 2000.
2. Herbst DS, Miller JR: Nonspecific X-linked mental retardation II: the frequency in British Columbia. Am J Med Genet 1980; 7: 461-469.
3. Fishburn J, Turner G, Daniel A, Brookwell R: The diagnosis and frequency of X-linked conditions in a cohort of moderately retarded males with affected brothers. Am J Med Genet 1983; 14: 713-724.
4. Gecz J, Mulley J: Genes for cognitive function: developments on the X. Genome Res 2000; 10: 157-163.
5. Chelly J, Mandel JL: Monogenic causes of X-linked mental retardation. Nat Rev 2001; 2: 669-679.
6. Ropers HH, Hoeltzenbein M, Kalscheuer V et al: Nonsyndromic X-linked mental retardation: where are the missing mutations? Trends Genet 2003; 19: 316-320.
7. Crawford DC, Acuna JM, Sherman S: FMR1 and the fragile X syndrome: human genome epidemiology review. Genet Med 2001; 3: 359-371.
8. Bundey S, Thake A, Todd J: The recurrence risks for mild idiopathic mental retardation. J Med Genet 1989; 26: 260-266.
9. Chiurazzi P, Hamel BC, Neri G: XLMR genes: update 2000. Eur J Hum Genet 2001; 9: 71-81.
10. des Portes V, Beldjord C, Chelly J et al: X-linked nonspecific mental retardation (MRX) linkage studies in 25 unrelated families: the European XLMR consortium. Am J Med Genet 1999; 85: 263-265.
11. Cason AL, Ikeguchi Y, Skinner C et al: X-linked spermine synthase gene (SMS) defect: the first polyamine deficiency syndrome. Eur J Hum Genet 2003; 11: 937-944.
12. Orrico A, Lam C, Galli L et al: MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett 2000; 481: 285-288.
13. Couvert P, Bienvenu T, Aquaviva C et al: MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet 2001; 10: 941-946.
14. Gomot M, Gendrot C, Verloes A et al: MECP2 gene mutations in non-syndromic X-linked mental retardation: phenotype-genotype correlation. Am J Med Genet 2003; 123A: 129-139.
15. Merienne K, Jacquot S, Pannetier S et al: A missense mutation in RPS6KA3 (RSK2) responsible for non-specific mental retardation (letter). Nat Genet 1999; 22: 13-14.
16. Yntema HG, Poppelaars FA, Derksen E et al: Expanding phenotype of XNP mutations: mild to moderate mental retardation. Am J Med Genet 2002; 110: 243-247.
17. Lebel RR, May M, Fouls S, Lubs HA, Stevenson RE, Schwartz CE: Non-syndromic X-linked mental retardation associated with a missense mutation (P312L) in the FGD1 gene. Clin Genet 2002; 61: 139-145.
18. Frints SG, Froyen G, Marynen F, Fryns JP: X-linked mental retardation: vanishing boundaries between non-specific (MRX) and syndromic (MRXS) forms. Clin Genet 2002; 62: 423-432.
19. Stevenson RE, Schwartz CE: Clinical and molecular contributions to the understanding of X-linked mental retardation. Cytogenet Genome Res 2002; 99: 265-275.
20. Biancalana V, Beldjord C, Taillandier A et al: Five years of molecular diagnosis of Fragile X syndrome (1997-2001): a collaborative study reporting 95% of the activity in France. Am J Med Genet 2004.
21. Yntema HG, Kleefstra T, Oudakker AR et al: Low frequency of MECP2 mutations in mentally retarded males. Eur J Hum Genet 2002; 10: 487-490.
22. Vervoort VS, Beachem MA, Edwards PS et al: AGTR2 mutations in X-linked mental retardation. Science 2002; 296: 2401-2403.
23. Bienvenu T, Poirier K, Van Esch H et al: Rare polymorphic variants of the AGTR2 gene in boys with non-specific mental retardation. J Med Genet 2003; 40: 357-359.
24. Erdmann J, Dahmlow S, Guse M, Hetzer R, Regitz-Zagrosek V: The assertion that a G21 V mutation in AGTR2 causes mental retardation is not supported by other studies. Hum Genet 2004; 114: 396, (author reply 397)
25. Stromme P, Mangelsdorf ME, Shaw MA et al: Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy. Nat Genet 2002; 30: 441-445.
26. Stromme P, Mangelsdorf ME, Scheffer IE, Gecz J: Infantile spasms, dystonia, and other X-linked phenotypes caused by mutations in Aristaless related homeobox gene, ARK. Brain Dev 2002; 24: 266-268.
27. Bienvenu T, Poirier K, Friocourt G et al: ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation. Hum Mol Genet 2002; 11: 981-991.
28. Jeanpierre M: Causal mutation or rare polymorphism? Frequency of mutation not found in n chromosome is less than 3 divided by n. Ann Genet 1996; 39: 133-138.
29. Collins JS, Schwartz CE: Detecting polymorphisms and mutations in candidate genes. Am J Hum Genet 2002; 71: 1251-1252.
30. Gronskov K, Hjalgrim H, Nielsen IM, Brondum-Nielsen K: Screening of the ARX gene in 682 retarded males. Eur J Hum Genet 2004; 12: 701-705.
31. Frints SGM: Clinical and Molecular Genetics or Mental Retardation (MR): From Phenotype to Genotype to Phenotype (PhD Dissertation), Faculty of Medicine, Dept of Human Genetics. Leuven; Katholieke Universiteit Leuven, 2002, p 150.
32. Crow YJ, Tolmie JL: Recurrence risks in mental retardation. J Med Genet 1998; 35: 177-182.
33. de Courten-Myers GM: The human cerebral cortex: gender differences in structure and function. J Neuropathol Exp Neurol 1999; 58: 217-226.
34. de Vries BB, van den Ouweland AM, Mohkamsing S et al: Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group. Am J Hum Genet 1997; 61: 660-667.
35. Philip N, Chabrol B, Lossi AM et al: Mutations in the oligophrenin-1 gene (OPHN1) cause X linked congenital cerebellar hypoplasia. J Med Genet 2003; 40: 441-446.
36. Bergmann C, Zerres K, Senderek J et al: Oligophrenin 1 (OPHN1) gene mutation causes syndromic X-linked mental retardation with epilepsy, rostral ventricular enlargement and cerebellar hypoplasia. Brain 2003; 126: 1537-1544.
37. des Portes V, Boddaert N, Sacco S et al: Specific clinical and brain MRI features in mentally retarded patients with mutations in the Oligophrenin-1 gene. Am J Med Genet 2004; 124A: 364-371.
38. Kalscheuer VM, Freude K, Musante L et al: Mutations in the polyglutamine binding protein 1 gene cause X-linked mental retardation. Nat Genet 2003; 35: 313-315.
39. Lenski C, Abidi F, Meindl A et al: Novel truncating mutations in the polyglutamine tract binding protein 1 gene (PQBP1) cause Renpenning syndrome and X-linked mental retardation in another family with microcephaly. Am J Hum Genet 2004; 74: 777-780.
40. Turner G, Partington M: Recurrence risks in undiagnosed mental retardation. J Med Genet 2000; 37: E45.